Independent UK Panel on Breast Cancer Screening replies to Michael BaumBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f873 (Published 13 February 2013) Cite this as: BMJ 2013;346:f873
- Michael Marmot, director1
- Independent UK Panel on Breast Cancer Screening: D G Altman (University of Oxford), D A Cameron (University of Edinburgh), J A Dewar (University of Dundee), S G Thompson (University of Cambridge), Maggie Wilcox (patient advocate).
- 1UCL Institute of Health Equity, UCL Dept of Epidemiology and Public Health, London WC1E 7HB, UK
Baum has raised interesting and important issues.1 The panel did not “duck” the effect of breast screening on all cause mortality. We indicated in the full report (p 32) that a 20% reduction in breast cancer mortality would reduce mortality from all cancers by only 3% and all cause mortality by 1.2%.2 The randomised trials performed lacked …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial